UB Paderborn / Katalog / Suche / in CDI

Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials

The Lancet (British edition), 2016-11, Vol.388 (10060), p.2629-2641

2016

Volltextzugriff (PDF)

The use of asthma controller medications during pregnancy and the risk of gestational diabetes

Journal of allergy and clinical immunology, 2016-12, Vol.138 (6), p.1732-1733.e6

2016

Volltextzugriff (PDF)

Atrial Fibrillation in a Structurally Normal Heart during Pregnancy: A Review of Cases From a Registry and From the Literature

Journal of obstetrics and gynaecology Canada, 2017-01, Vol.39 (1), p.18-24

2017

Volltextzugriff (PDF)

Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy

Annals of allergy, asthma, & immunology, 2014-05, Vol.112 (5), p.459-464

2014

Volltextzugriff (PDF)

Low-dose ASA Response Using the PFA-100 in Women With High-risk Pregnancy

Journal of obstetrics and gynaecology Canada, 2009-11, Vol.31 (11), p.1022-1027

2009

Volltextzugriff (PDF)

Risk of perinatal mortality associated with inhaled corticosteroid use for the treatment of asthma during pregnancy

Journal of allergy and clinical immunology, 2010-10, Vol.126 (4), p.772-777.e2

2010

Volltextzugriff (PDF)

Preeclampsia: Should Plasma Albumin Level Be a Criterion for Severity?

Journal of obstetrics and gynaecology Canada, 2011-09, Vol.33 (9), p.922-926

2011

Volltextzugriff (PDF)

Venous Thromboembolism and Antithrombotic Therapy in Pregnancy

Journal of obstetrics and gynaecology Canada, 2014-06, Vol.36 (6), p.527-553

2014

Volltextzugriff (PDF)

Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary

Journal of obstetrics and gynaecology Canada, 2014-05, Vol.36 (5), p.416-438

2014

Volltextzugriff (PDF)

Maternal Asthma, its Control and Severity in Pregnancy, and the Incidence of Atopic Dermatitis and Allergic Rhinitis in the Offspring

The Journal of pediatrics, 2009-11, Vol.155 (5), p.707-713.e1

2009

Volltextzugriff (PDF)

Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women

American journal of obstetrics and gynecology, 2010-10, Vol.203 (4), p.383.e1-383.e8

2010

Volltextzugriff (PDF)

Risk of perinatal mortality associated with asthma during pregnancy: a 2-stage sampling cohort study

Annals of allergy, asthma, & immunology, 2010-09, Vol.105 (3), p.211-217

2010

Volltextzugriff (PDF)

Use of short-acting β2 -agonists during pregnancy and the risk of pregnancy-induced hypertension

Journal of allergy and clinical immunology, 2007-03, Vol.119 (3), p.576-582

2007

Volltextzugriff (PDF)

Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy

Journal of obstetrics and gynaecology Canada, 2008-03, Vol.30 (3), p.S1-S2

2008

Volltextzugriff (PDF)

The hypertensive disorders of pregnancy (29.3)

Best practice & research. Clinical obstetrics & gynaecology, 2015-07, Vol.29 (5), p.643-657

2015

Volltextzugriff (PDF)

Validity of a modified Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy

American journal of obstetrics and gynecology, 2008, Vol.198 (1), p.71.e1-71.e7

2008

Volltextzugriff (PDF)

Diagnostic, évaluation et prise en charge des troubles hypertensifs de la grossesse : Résumé directif

Journal of obstetrics and gynaecology Canada, 2016-12, Vol.38 (12), p.S426-S452

2016

Volltextzugriff (PDF)

Diagnostic, évaluation et prise en charge des troubles hypertensifs de la grossesse : Résumé directif

Journal of obstetrics and gynaecology Canada, 2014-05, Vol.36 (5), p.439-441

2014

Volltextzugriff (PDF)

The Urinary Protein-to-Creatinine Ratio in Canadian Women at Risk of Preeclampsia: Does the Time of Day of Testing Matter?

Journal of obstetrics and gynaecology Canada, 2014-04, Vol.36 (4), p.303-308

2014

Volltextzugriff (PDF)

Discontinuation of antihypertensive drug use during the first trimester of pregnancy and the risk of preeclampsia and eclampsia among women with chronic hypertension

American journal of obstetrics and gynecology, 2009-08, Vol.201 (2), p.180.e1-180.e8

2009

Volltextzugriff (PDF)

Thromboembolie veineuse et traitement antithrombotique pendant la grossesse

Journal of obstetrics and gynaecology Canada, 2014-06, Vol.36 (6), p.554-558

2014

Volltextzugriff (PDF)

“34 Weeks” of Gestation—Lost in Translation

Journal of obstetrics and gynaecology Canada, 2014-06, Vol.36 (6), p.480-481

2014

Volltextzugriff (PDF)

Dalteparin and Low-Dose Aspirin in the Prevention of Adverse Obstetric Outcomes in Women With Inherited Thrombophilia

Journal of obstetrics and gynaecology Canada, 2007-10, Vol.29 (10), p.787-793

2007

Volltextzugriff (PDF)

In Response

Journal of obstetrics and gynaecology Canada, 2014, Vol.36 (7), p.575-576

2014

Volltextzugriff (PDF)

Prevention of Adverse Pregnancy Outcomes With Low-Dose ASA in Early Pregnancy: New Perspectives for Future Randomized Trials

Journal of obstetrics and gynaecology Canada, 2011-05, Vol.33 (5), p.480-483

2011

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials

The use of asthma controller medications during pregnancy and the risk of gestational diabetes

Atrial Fibrillation in a Structurally Normal Heart during Pregnancy: A Review of Cases From a Registry and From the Literature

Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy

Low-dose ASA Response Using the PFA-100 in Women With High-risk Pregnancy

Risk of perinatal mortality associated with inhaled corticosteroid use for the treatment of asthma during pregnancy

Preeclampsia: Should Plasma Albumin Level Be a Criterion for Severity?

Venous Thromboembolism and Antithrombotic Therapy in Pregnancy

Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary

Maternal Asthma, its Control and Severity in Pregnancy, and the Incidence of Atopic Dermatitis and Allergic Rhinitis in the Offspring

Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women

Risk of perinatal mortality associated with asthma during pregnancy: a 2-stage sampling cohort study

Use of short-acting β2 -agonists during pregnancy and the risk of pregnancy-induced hypertension

Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy

The hypertensive disorders of pregnancy (29.3)

Validity of a modified Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy

Diagnostic, évaluation et prise en charge des troubles hypertensifs de la grossesse : Résumé directif

Diagnostic, évaluation et prise en charge des troubles hypertensifs de la grossesse : Résumé directif

The Urinary Protein-to-Creatinine Ratio in Canadian Women at Risk of Preeclampsia: Does the Time of Day of Testing Matter?

Discontinuation of antihypertensive drug use during the first trimester of pregnancy and the risk of preeclampsia and eclampsia among women with chronic hypertension

Thromboembolie veineuse et traitement antithrombotique pendant la grossesse

“34 Weeks” of Gestation—Lost in Translation

Dalteparin and Low-Dose Aspirin in the Prevention of Adverse Obstetric Outcomes in Women With Inherited Thrombophilia

In Response

Prevention of Adverse Pregnancy Outcomes With Low-Dose ASA in Early Pregnancy: New Perspectives for Future Randomized Trials

Suchergebnisse filtern